However, we observed no statistical difference in MSUT2 levels between PSP and CTR brains in the immunoblots, in keeping with the non-significant trend observed by immunofluorescence staining (Fig. 1f and l). This evidence concerns the gene ZC3H14 and supranuclear palsy, progressive, 1.